| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |